KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Edwards Lifesciences (EW) Inventory (2016 - 2025)

Edwards Lifesciences has reported Inventory over the past 17 years, most recently at $1.1 billion for Q4 2025.

  • Quarterly results put Inventory at $1.1 billion for Q4 2025, up 3.63% from a year ago — trailing twelve months through Dec 2025 was $1.1 billion (up 3.63% YoY), and the annual figure for FY2025 was $1.1 billion, up 3.63%.
  • Inventory for Q4 2025 was $1.1 billion at Edwards Lifesciences, down from $1.1 billion in the prior quarter.
  • Over the last five years, Inventory for EW hit a ceiling of $1.2 billion in Q1 2024 and a floor of $726.7 million in Q4 2021.
  • Median Inventory over the past 5 years was $947.2 million (2023), compared with a mean of $943.6 million.
  • Biggest five-year swings in Inventory: dropped 9.42% in 2021 and later surged 36.24% in 2023.
  • Edwards Lifesciences' Inventory stood at $726.7 million in 2021, then rose by 20.48% to $875.5 million in 2022, then increased by 3.2% to $903.5 million in 2023, then increased by 20.28% to $1.1 billion in 2024, then rose by 3.63% to $1.1 billion in 2025.
  • The last three reported values for Inventory were $1.1 billion (Q4 2025), $1.1 billion (Q3 2025), and $1.1 billion (Q2 2025) per Business Quant data.